Family Medicine · Burbank, CA
NPI
1669578811
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
303 S Glenoaks Blvd, Suite #4
Burbank, CA, 91502
Phone (818) 845-7228
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
1,575 services
Medicare patients, 2024
105
Average age 68
Drug cost, 2024
$426K
3,431 prescriptions
Company payments, 2025
$188
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lynn J Ramirez was code 99232 (hospital e&m - subsequent), 1,094 times for 60 patients. In total Lynn J Ramirez billed 1,575 services in 18 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,094 | 60 | $64.84 | $71K |
| 99308 SNF E&M | Facility | 183 | 20 | $62.71 | $11K |
| 99223 Hospital E&M - Initial | Facility | 100 | 57 | $141.90 | $14K |
| 99213 Office E&M - Established | Office | 91 | 36 | $71.45 | $6,502 |
| 99214 Office E&M - Established | Office | 50 | 34 | $101.15 | $5,057 |
| 99305 SNF E&M | Facility | 23 | 19 | $111.16 | $2,557 |
By year: 2022 $78K for 1,094 services; 2023 $83K for 1,131 services; 2024 $114K for 1,575 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lynn J Ramirez prescribed most often to Medicare patients was Levothyroxine Sodium, with 192 prescriptions and refills. In total Lynn J Ramirez wrote 3,431 Medicare prescriptions that cost $426K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 192 | 269 | 30 | $1,468 |
| Tamsulosin Hcl Generic | 141 | 194 | 27 | $1,745 |
| Eliquis Apixaban | 105 | 105 | 14 | $31K |
| Fenofibrate Fenofibrate Nanocrystallized | 102 | 117 | 14 | $1,720 |
| Tradjenta Linagliptin | 101 | 115 | 16 | $43K |
| Atorvastatin Calcium Generic | 92 | 136 | 19 | $545 |
| Rosuvastatin Calcium Generic | 88 | 140 | 15 | $1,012 |
| Jardiance Empagliflozin | 80 | 83 | 16 | $45K |
| Januvia Sitagliptin Phosphate | 78 | 91 | Under 11 | $35K |
| Metoprolol Succinate Generic | 74 | 108 | 13 | $993 |
| Potassium Chloride Generic | 72 | 75 | 15 | $751 |
| Farxiga Dapagliflozin Propanediol | 57 | 75 | Under 11 | $32K |
| Pantoprazole Sodium Generic | 56 | 65 | Under 11 | $458 |
| Olanzapine Generic | 54 | 55 | Under 11 | $566 |
| Quetiapine Fumarate Generic | 51 | 52 | Under 11 | $914 |
Brand drugs: 743 claims; generic drugs: 2,658 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lynn J Ramirez $188 ($188 in general payments such as food, travel and fees) from 3 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $126.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.